Skip to main content
. 2022 Apr 9;193(2):437–444. doi: 10.1007/s10549-022-06585-5

Fig. 4.

Fig. 4

Overall Survival (days) in Patients with MBC for those with < 5 CTCs per 7.5 ml of whole blood and those in the group with ≥ 5 CTCs in 7.5 ml of whole blood (n = 86). A Cellsearch count with a log-rank HR 5.64 (2.579–10.34) (p < 0.0001). B RareCyte count with a log-rank HR 4.213 (2.153–8.244) (p < 0.0001)